April 26, 2024
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549-3720
Attention: Joshua Gorsky
| Re: | Aadi Bioscience, Inc. |
Registration Statement on Form S-3
File No. 333-277018
Acceleration Request
| Requested Date: | April 30, 2024 | |
| Requested Time: | 4:00 p.m. Eastern Time, or as soon thereafter as practicable |
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Aadi Bioscience, Inc. (the “Company”) hereby requests that its Registration Statement on Form S-3 (File No. 333-277018) (the “Registration Statement”) be declared effective at the “Requested Date” and “Requested Time” set forth above or at such later time as the Company or its counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the Securities and Exchange Commission. Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Wilson Sonsini Goodrich & Rosati, P.C., by calling Robert Wernli at (858) 350-2273.
| Sincerely, | ||
| AADI BIOSCIENCE, INC. | ||
| By: | /s/ David Lennon | |
| David Lennon | ||
| Chief Executive Officer | ||
| cc: | Steve Rodin, Aadi Bioscience, Inc. |
Dan Koeppen, Wilson Sonsini Goodrich & Rosati
Robert Wernli, Wilson Sonsini Goodrich & Rosati